These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3034739)

  • 21. [Do ACE inhibitors reduce morbidity and mortality in arterial hypertension?].
    Ritzmann P
    Praxis (Bern 1994); 1999 Nov; 88(48):2005-6. PubMed ID: 10608185
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertensive emergencies in old age: effects of angiotensin converting enzyme inhibition.
    Marigliano V; Santilli D; Fiorani M; Ariani A; Cacciafesta M; Ferri C; Piccirillo G
    J Hypertens Suppl; 1988 Nov; 6(1):S91-3. PubMed ID: 3063797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 24. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 25. [Do we need more ACE inhibitors?].
    Haugen O
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1411. PubMed ID: 2187274
    [No Abstract]   [Full Text] [Related]  

  • 26. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
    Djordjević VB; Pavlović D; Pejović M; Cvetković T; Lecić N; Deljanin-Ilić M
    Clin Nephrol; 1997 Apr; 47(4):243-7. PubMed ID: 9128791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 36. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B
    Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 40. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.